Tailoring lipid nanoparticles for T-cell targeting in allergic asthma: Insights into efficacy and specificity.
Ontology highlight
ABSTRACT: Asthma impacts over 300 million patients globally, with significant health implications, especially in cases of its allergic subtype. The disease is characterized by a complex interplay of airway inflammation and immune responses, often mediated by Th2 cell-related cytokines. In this study, we engineered lipid nanoparticles (LNPs) to specifically deliver therapeutic siRNA via the transferrin receptor to T cells. Strain-promoted azide-alkyne cycloaddition (SPAAC) was employed for the conjugation of transferrin ligands to PEGylated lipids in the LNPs, with the goal of enhancing cellular uptake and gene knockdown. The obtained LNPs exhibited characteristics that make them suitable for pulmonary delivery. Using methods such as nanoparticle tracking analysis (NTA) and enzyme-linked i
SUBMITTER: Jurgens DC
PROVIDER: S-EPMC7616735 | biostudies-literature | 2024 May
REPOSITORIES: biostudies-literature
ACCESS DATA